SecBot SecBot

Share the Savings with Seniors Act

H.R. 5376 Rep. Mariannette Miller-Meeks (R-IA-1) In committee
Bill text PDF
  1. Introduced Sep 8
  2. Committee Sep 8
  3. Passed House Next
  4. Passed Senate Not yet
  5. To President Not yet
  6. Law Not yet
Where it stands
In committee, Sep 8, 2023Next: House vote
680d ago Dec 17, 2024: Referred to the Subcommittee on Health.
Final votes
No roll callsNo recorded vote on this bill yet
Lobbying
62companies, 131 filings
Subscribe to see spend
Member trades
89trades in the last 90 days
Subscribe to see who
Who backs the bill and who pushes back Subscribe

Companies lobbying on this bill

62 companies
Companies by sector
Energy 20Biotech & Pharma 11Industrials 9Consumer & Retail 4Financials 4Mining & Materials 4Technology & Software 4Communications & Media 2
Search all 62 companies, their asks and price moves Subscribe

Summary

Share the Savings with Seniors Act

Full summary2 paragraphs

This bill limits cost-sharing for chronic care drugs under the Medicare prescription drug benefit. Chronic care drugs include blood glucose regulators other than insulin, anticoagulants, and other categories of drugs as specified in the bill.

Specifically, for costs below the annual deductible, the bill caps cost-sharing for chronic care drugs at the net price of the drug (i.e., the negotiated price net of all manufacturer price concessions); for costs above the annual deductible and below the annual out-of-pocket threshold, cost-sharing must be based on a percentage of the drug's net price (if cost-sharing for that drug is tied to the price or cost of the drug).

Library of Congress summary, Sep 8, 2023

Summary versions
  • Introduced in HouseSep 8, 2023

Official record from Congress.gov, the House Clerk and the Senate; lobbying from Lobbying Disclosure Act filings. Updated Oct 28, 2026.